Skip to main content

"SysPharmAD", a project to stop Alzheimer's disease

Participants

Contact

Image
Press & Communications Section Head
Tel.+34 93 40 37255

In an interview in the e-News bulletin produced by Biocat, ICREA researcher Patrick Aloy explains the objectives of the Alzheimer's disease project awarded an ERC Consolidator Grant of 1.3 million euros.

Read the interview with Patrick Aloy in Biocat

Related news:

14 January 2014
IRB receives 1.3 M€ from the European Research Council for investigation into Alzheimer’s disease

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).